Core Viewpoint - Shenwan Hongyuan (06806) announced the completion of the issuance of short-term corporate bonds aimed at professional investors, with a total issuance scale of RMB 3.9 billion [1] Group 1: Bond Issuance Details - The bond issuance consists of two varieties: the first variety has an issuance scale of RMB 800 million, a term of 186 days, and a coupon rate of 1.70% [1] - The second variety has an issuance scale of RMB 3.1 billion, a term of 242 days, and a coupon rate of 1.75% [1] Group 2: Trading Information - The bonds are scheduled to be listed and traded on the Shenzhen Stock Exchange starting from August 29, 2025 [1] - The first variety of bonds is referred to as "25申证D7" with the bond code "134464", while the second variety is referred to as "25申证D8" with the bond code "134465" [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲 明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 董事長 劉健 北京，2025年9月1日 於本公告日期，董事會成員包括執行董事劉健先生及黃昊先生；非執行董事朱志龍先生、張英女士、邵亞樓先生、 徐一心先生及嚴金國先生；獨立非執行董事楊小雯女士、武常岐先生、陳漢文先生及趙磊先生。 证券代码：000166 证券简称：申万宏源 公告编号：临2025-69 （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） （股份代號：6806） 海外監管公告 本公告乃由申萬宏源集團股份有限公司（「本公司」）根據香港聯合交易所有限公司證券上市規 則第13.10B條作出。 茲載列本公司於深圳證券交易所網站發佈之《申萬宏源集團股份有限公司關於申萬宏源證券有 限公司2025年面向專業投資者非公開發行短期公司債券（第五期）發行結果的公告》，僅供參 閱。 承董事會命 申萬宏源集團股份有限公司 2025 年 8 月 29 日，申万宏源证券有限公司 2025 年面 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲 明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） （股份代號：6806） 申 万 宏 源 集 团 股 份 有 限 公 司 关于申万宏源证券有限公司 2025 年面向专业投资者 非公开发行短期公司债券（第四期）在深圳证券交易所 挂牌转让的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 海外監管公告 本公告乃由申萬宏源集團股份有限公司（「本公司」）根據香港聯合交易所有限公司證券上市規 則第13.10B條作出。 茲載列本公司於深圳證券交易所網站發佈之《申萬宏源集團股份有限公司關於申萬宏源證券有 限公司2025年面向專業投資者非公開發行短期公司債券（第四期）在深圳證券交易所掛牌轉讓 的公告》，僅供參閱。 承董事會命 申萬宏源集團股份有限公司 董事長 劉健 北京，2025年9月1日 於本公告日期，董事會成員包括執行董事劉健先生及 ...

Group 1 - The company has announced the issuance of short-term corporate bonds amounting to a total face value of up to RMB 20 billion for its subsidiary, Shenwan Hongyuan Securities Co., Ltd. [1] - The issuance of the fifth phase of short-term corporate bonds has been completed, with a total issuance scale of RMB 3.6 billion, divided into two varieties [2] - The first variety has an issuance scale of RMB 1 billion, with a term of 181 days and a coupon rate of 1.71%, while the second variety has an issuance scale of RMB 2.6 billion, with a term of 243 days and a coupon rate of 1.75% [2]

证券代码：000166 证券简称：申万宏源 公告编号：临2025-69 申 万 宏 源 集 团 股 份 有 限 公 司 关于申万宏源证券有限公司 2025 年面向专业投资者 非公开发行短期公司债券（第五期）发行结果的公告 二〇二五年九月一日 2025 年 8 月 29 日，申万宏源证券有限公司 2025 年面向专业投 资者非公开发行短期公司债券（第五期）（以下简称"本期债券"）完 成发行工作。本期债券发行规模人民币 36 亿元，分两个品种，其中 品种一发行规模人民币 10 亿元，期限 181 天，票面利率 1.71%；品 种二发行规模人民币 26 亿元，期限 243 天，票面利率 1.75%。本期 债券登记完成后拟于深圳证券交易所挂牌转让。 特此公告。 申万宏源集团股份有限公司董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 根据深圳证券交易所《关于申万宏源证券有限公司非公开发行短 期公司债券符合深交所挂牌条件的无异议函》（深证函〔2025〕461 号），公司所属申万宏源证券有限公司获准面向专业投资者非公开发 行面值总额不超过人民币 200 亿元短期公司 ...

证券代码：000166 证券简称：申万宏源 公告编号：临2025-70 申 万 宏 源 集 团 股 份 有 限 公 司 关于申万宏源证券有限公司 2025 年面向专业投资者 非公开发行短期公司债券（第四期）在深圳证券交易所 挂牌转让的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 经深圳证券交易所审核，本期债券定于2025 年8月29日起在深圳 证券交易所挂牌转让，面向专业投资者中的机构投资者交易，品种一 债券简称"25申证D7"，债券代码为"134464"；品种二债券简称"25 申证D8"，债券代码为"134465"。 特此公告。 申万宏源集团股份有限公司董事会 二〇二五年九月一日 公司所属子公司申万宏源证券有限公司 2025 年面向专业投资者 非公开发行短期公司债券（第四期）（以下简称"本期债券"）发行工 作于 2025 年 8 月 25 日完成，本期债券发行规模人民币 39 亿元，分 两个品种，其中品种一发行规模人民币 8 亿元，期限 186 天，票面利 率 1.70%；品种二发行规模人民币 31 亿元，期限 242 天，票面利率 1.75%。（相 ...

Core Viewpoint - The company, Brother Technology, has shown positive financial performance in the first half of 2025, with significant growth in net profit and a focus on optimizing production costs and expanding product applications in various industries [6]. Financial Performance - In the first half of 2025, the company reported a main revenue of 1.811 billion yuan, an increase of 3.45% year-on-year [6]. - The net profit attributable to shareholders reached 64.541 million yuan, a substantial increase of 357.17% year-on-year [6]. - The net profit after deducting non-recurring items was 62.531 million yuan, up 463.49% year-on-year [6]. - In Q2 2025, the company recorded a single-quarter main revenue of 892 million yuan, a decrease of 4.16% year-on-year [6]. - The single-quarter net profit attributable to shareholders was 43.6329 million yuan, an increase of 10.96% year-on-year [6]. - The single-quarter net profit after deducting non-recurring items was 43.8077 million yuan, up 18.74% year-on-year [6]. - The company's debt ratio stood at 46.73%, with investment income of -85,800 yuan and financial expenses of 27.1813 million yuan [6]. - The overall gross margin was 18.42% [6]. Product Development and Market Strategy - The company is continuously optimizing production processes and releasing project capacities, particularly in iodine contrast agents and phenol products [2]. - The order method for vitamin products primarily consists of quarterly and monthly orders, with prices based on market conditions [3]. - The company has successfully introduced para-phenol into the PEEK field, completing sample submissions to major domestic PEEK manufacturers, with some clients already validating the product [4]. - The company has a production capacity of 20,000 tons for both ortho-phenol and para-phenol, with applications in various industries including food, daily chemicals, pesticides, pharmaceuticals, dyes, and high polymer materials [5]. - The largest application area currently is in acrylic acid inhibitors, while the PEEK field shows the most growth potential in the future [5]. Industry Context - The iodine contrast agent sector is currently facing challenges due to high raw material prices, centralized procurement policies, and industry competition, but the company's gross margin for these products is expected to improve as market access conditions are met and production capacity is released [6].

Financial Performance - In the first half of 2025, the company achieved a consolidated revenue of CNY 11.695 billion, representing a year-on-year increase of 44.44% [3] - The net profit for the same period was CNY 4.803 billion, with a year-on-year growth of 67.78% [3] - The weighted average return on net assets was 4.00%, an increase of 1.91 percentage points compared to the previous year [3] Business Segments - The securities investment trading business generated investment income and fair value changes totaling CNY 7.681 billion, up 48.04% year-on-year [3] - Wealth management saw an increase of 510,000 new clients, with total client assets reaching CNY 4.77 trillion, and net income from brokerage fees was CNY 2.487 billion, a growth of 31.47% [3] - The investment banking segment achieved net income of CNY 627 million, a 49.12% increase year-on-year, with 8 equity underwriting cases, ranking 7th in the industry [4] International Expansion - The company established a comprehensive overseas business platform centered in Hong Kong, with a profit of HKD 174 million, a 519% increase year-on-year [5] - Plans to enhance wealth management, asset management, and investment banking capabilities in international markets were outlined [5] Risk Management - As of June 2025, the risk coverage ratio was 400.70%, an increase of 16.66 percentage points from the previous year [6] - The company has implemented a comprehensive risk management system to effectively control operational risks [6] Strategic Development - The company aims to integrate its services with national strategic development, focusing on wealth management, institutional trading, and investment banking [7] - Future strategies include enhancing core capabilities and expanding into new markets, particularly in emerging industries [7] Fund Management - As of June 2025, the public fund management scale of Shenwan Hongyuan was approximately CNY 82.8 billion, while the total assets of Fortune Fund exceeded CNY 1.7 trillion [8] - Plans to improve service quality and expand product offerings were discussed to enhance competitiveness [8] Derivatives and Trading - The company added 5 new commodity options market-making licenses, maintaining a leading position in the industry [9] - The institutional services and trading business generated revenue of CNY 5.130 billion, a year-on-year increase of 71.20% [10] - The main brokerage business saw a significant increase in demand, with revenue from seat leasing reaching CNY 216 million [10]

Group 1 - The "Second Golden Unicorn Best Investment Advisor Selection" event is currently ongoing, organized by Sina Finance in collaboration with Yinhua Fund, aiming to identify outstanding investment advisors and enhance the investment advisory IP construction [1] - The monthly ranking data for August shows that the top investment advisor in the public fund simulation configuration group is Wu Dayao from Guoyuan Securities, achieving a monthly return of 31.32% [1][2] - The second and third positions are held by Hong Xiaowei from Founder Securities with a return of 26.25% and Zhang Kun from GF Securities with a return of 23.07% respectively [1][2] Group 2 - The top 100 rankings for the public fund simulation configuration group for August include notable advisors such as Zhang Yefeng from Guotai Junan Securities with a return of 22.88% and Liu Jiafeng from Guoxin Securities with a return of 21.04% [2][3] - The performance of the top advisors indicates a competitive environment in the investment advisory sector, with several advisors achieving returns above 20% [2][3] - The rankings reflect the effectiveness of different investment strategies employed by various advisors across multiple securities firms [1][2]

Core Viewpoint - Jinma Amusement (SZ 300756) announced a scheduled investor meeting on August 29, 2025, where the company's Deputy General Manager and Board Secretary, Zeng Qingyuan, will address investor inquiries [1] Company Summary - For the fiscal year 2024, Jinma Amusement's revenue composition is as follows: large amusement facilities account for 90.49% and amusement investment and operation business accounts for 9.51% [1]